Chimerix
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · North Carolina, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
2505 Meridian Pkwy Ste 100, Durham, Nort...Phone Number
(919) 806-1074Website
www.chimerix.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Chimerix
Chimerix, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines that address unmet medical needs in the United States. The companys lead product candidate is brincidofovir, an investigational nucleoside analog for the prevention of serious viral infections in hematopoietic or stem cell transplant recipients (HCT), as well as for the treatment of serious adenovirus infection and disease, smallpox, and BK virus infection in kidney and HCT transplant recipients. It is also developing CMX521, a nucleoside analog that is in preclinical stage for the treatment and prevention of norovirus; and CMX157, a nucleoside analog, which is in Phase II clinical stage to treat HIV and hepatitis B virus infection. It has a license agreement with ContraVir Pharmaceuticals for the development and commercialization of brincidofovir and CMX157 for certain antiviral indications; and BARDA for the development of brincidofovir for the treatment of smallpox. Chimerix, Inc. was founRead more
Chimerix Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Chimerix your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Check out if Chimerix is spiking on competitors!
Check if Chimerix has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Chimerix recently announced quarterly report
Chimerix, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Chimerix has new funding data
Congratulate Masked Content for being promoted to Masked Content at Chimerix
Product Launch: Get notified when Chimerix launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Chimerix had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Chimerix
Compare insights from companies similar to Chimerix, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Chimerix is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Chimerix is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Chimerix.
Chimerix financials insights
Gather financial insights about Chimerix, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2002
Series A
$1M
2003
Series B
$3.1M
Unspecified
$36.1M
2004
Series C
$11M
2007
Series D
$23.1M
2009
Other Financing Round
$16.1M
2011
Other Financing Round
$45M
2013
Stock Offering
$102.5M
Chimerix Tech Stack
A closer look at the technologies used by Chimerix
Most Recent Scoops
Left Company
Executive Move
Executive Moves, Left Company
Project
Chimerix is considering the purchase of solutions related to community management such as Nationbuilder, Meetup Pro.
Spending/Investment, Customer Experience, Customer Retention & Development
Left Company
Executive Move
Executive Moves, Left Company
Left Company
Executive Move
Executive Moves, Left Company
Left Company
Executive Move
Executive Moves, Left Company
Chimerix News & Media
Jazz Pharmaceuticals Completes Acquisition of Chimerix
- Addition of dordaviprone strengthens Jazz's late-stage oncology pipeline and reinforces commitment to addressing rare diseases with significant unmet need - DUBLIN, April 21, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) ("Jazz" or the "Company") today announced the...Is Chimerix Inc. (CMRX) the Best Performing NASDAQ Stock So Far in 2025?
We recently published a list of 11 Best Performing NASDAQ Stocks So Far in 2025. In this article, we are going to take a look at where Chimerix Inc. (NASDAQ:CMRX) stands against other best performing NASDAQ stocks so far in 2025. On March 29, T. Rowe Price portfolio manager Tony Wang appeared on CNBC’s ‘Closing […]Chimerix (NASDAQ:CMRX) Now Covered by StockNews.com - MarketBeat
StockNews.com started coverage on Chimerix in a report on Sunday. They issued a "hold" rating on the stock.Chimerix Reports Fourth Quarter and Year End 2024 Financial Results
New Drug Application (NDA) for Dordaviprone as Treatment for Recurrent H3 K27M-Mutant Diffuse Glioma Under Review with Prescription Drug User Fee Act (PDUFA) Action Date of August 18, 2025
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Chimerix
Sign Up For FreeTo access detailed company insights
Chimerix, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines that address unmet medical needs in the United States. The companys lead product candidate is brincidofovir, an investigational nucleoside analog for the prevention of serious viral infections in hematopoietic or stem cell transplant recipients (HCT), as... Read More
